Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Cash & Equivalents Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Cash & Equivalents Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -13.31%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -7.03%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.09%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 34.27%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 8.16%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 40.74%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 27.03%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -2.57%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 32.23%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -55.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.73%
Mar 31, 2026 -66.95%
Dec 31, 2025 -82.30%
Sep 30, 2025 -56.86%
Mar 31, 2025 -69.54%
Dec 31, 2024 -42.41%
Sep 30, 2024 -60.20%
Jun 30, 2024 -90.75%
Mar 31, 2024 -54.53%
Dec 31, 2023 -46.97%
Sep 30, 2023 -44.99%
Jun 30, 2023 -36.82%
Mar 31, 2023 -12.82%
Dec 31, 2022 2.83%
Sep 30, 2022 -1.90%
Mar 31, 2022 -31.53%
Dec 31, 2021 -38.38%
Sep 30, 2021 61.27%
Mar 31, 2021 31.08%
Dec 31, 2020 42.64%